6Kirchner L,Weninger M,Unterasinger L,et al.Is the use of early nasal CPAP associated with lower rates of chronic lung disease and retinopathy of prematuring? Nine years of experience with the Vermont Oxford Neonatal Net work.J Perinat Med,2005,33(1):60-66.
9Ali N,Claure N,Alegria X,et al.Effect s of non-invasive pressure support ventilation(NIPSV)on ventilation and respiratory effort in very low birth weight infants.Pediatr Pulmonol,2007,42 (8):704-710.
5Suresh GK, Soll RF. Exogenous surfactant therapy in newborn infants. Ann Acad Meal Singapore, 2003, 32 : 335.
6Fiori HH, Varela I, Gusto AL, et al. Stable microbubble test and click test to predict respiratory distress syndrome in preterm infants not requiring ventilated at birth. J Perinat Med, 2003, 31: 509.
7Teeratakulpisarn J, Taksaphan S, Pengsaa K, et al.Prediction of idiopathic respiratory distress syndrome by the stable microbubble test on gastric aspirate. Pediatr Pulmonol, 1998, 25: 383.
8Halliday HL. History of surfactant from 1980. Biol Neonate, 2005,87: 317-22.
9Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Bey, 2001 : CD000144.
10Milligan DW, Ainsworth SB. Animal-derived or synthetic surfactant for the treatment of neonatal respiratory distress syndrome: a review.Acta Paediatr, 2001,90 Suppl: 25.
